Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for ex vivo Diagnostics

Ana Copaescu; Phuti Choshi; Sarah Pedretti; Effie Mouhtouris; Jonathan Peter; Jason A Trubiano

doi:10.3389/fphar.2021.758192

Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for ex vivo Diagnostics

Front Pharmacol. 2021 Sep 2:12:758192. doi: 10.3389/fphar.2021.758192. eCollection 2021.

Authors

Ana Copaescu¹, Phuti Choshi², Sarah Pedretti³, Effie Mouhtouris¹, Jonathan Peter^{2

3}, Jason A Trubiano^{1

4

5

6}

Affiliations

¹ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.
² Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
³ Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
⁴ Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia.
⁵ Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.
⁶ The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.640012.].

Keywords: cytotoxicity; delayed hypersensitivity reaction; drug allergy; enzyme link immunospot; flow cytoametry; lactate dehydrogenase; severe cutaneous adverse reaction; t-cell.

Publication types

Published Erratum